| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Interferon-gamma Release Tests | 4 | 2019 | 253 | 1.42 | Why? |
| Candida | 4 | 2020 | 425 | 0.97 | Why? |
| Microbial Sensitivity Tests | 12 | 2020 | 2886 | 0.90 | Why? |
| Latent Tuberculosis | 4 | 2019 | 324 | 0.90 | Why? |
| Candidiasis | 4 | 2019 | 334 | 0.86 | Why? |
| Bacterial Proteins | 3 | 2019 | 1318 | 0.84 | Why? |
| Iran | 26 | 2021 | 5467 | 0.83 | Why? |
| Drug Resistance, Multiple, Bacterial | 5 | 2020 | 1115 | 0.70 | Why? |
| Helicobacter Infections | 2 | 2018 | 216 | 0.69 | Why? |
| Shigella | 1 | 2017 | 27 | 0.69 | Why? |
| Clarithromycin | 2 | 2018 | 112 | 0.68 | Why? |
| Helicobacter pylori | 2 | 2018 | 262 | 0.68 | Why? |
| Referral and Consultation | 9 | 2021 | 4816 | 0.67 | Why? |
| Salmonella | 1 | 2017 | 58 | 0.67 | Why? |
| Keratitis | 1 | 2018 | 102 | 0.67 | Why? |
| Liver Failure, Acute | 1 | 2020 | 279 | 0.65 | Why? |
| Gram-Negative Bacteria | 2 | 2020 | 473 | 0.62 | Why? |
| Malaria Vaccines | 1 | 2017 | 90 | 0.62 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.62 | Why? |
| Antifungal Agents | 7 | 2020 | 1828 | 0.61 | Why? |
| Drug Resistance, Bacterial | 4 | 2019 | 1414 | 0.61 | Why? |
| Arthritis, Infectious | 1 | 2017 | 111 | 0.61 | Why? |
| Klebsiella pneumoniae | 2 | 2019 | 658 | 0.60 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.60 | Why? |
| Whooping Cough | 1 | 2018 | 201 | 0.59 | Why? |
| Eye Infections, Fungal | 1 | 2018 | 252 | 0.58 | Why? |
| Metapneumovirus | 1 | 2018 | 465 | 0.57 | Why? |
| Microscopy | 1 | 2018 | 414 | 0.56 | Why? |
| Fungi | 1 | 2018 | 471 | 0.56 | Why? |
| Point Mutation | 1 | 2017 | 481 | 0.54 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.53 | Why? |
| Klebsiella Infections | 1 | 2019 | 466 | 0.52 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.50 | Why? |
| Malaria, Falciparum | 1 | 2017 | 377 | 0.47 | Why? |
| beta-Lactamases | 1 | 2019 | 759 | 0.47 | Why? |
| Mycobacterium tuberculosis | 3 | 2019 | 1164 | 0.47 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.47 | Why? |
| Staphylococcal Infections | 2 | 2017 | 1099 | 0.43 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2018 | 846 | 0.42 | Why? |
| Anti-Bacterial Agents | 8 | 2020 | 10083 | 0.42 | Why? |
| Otomycosis | 2 | 2019 | 2 | 0.39 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.39 | Why? |
| Child, Preschool | 23 | 2021 | 36283 | 0.37 | Why? |
| Hospitals, Pediatric | 1 | 2017 | 1792 | 0.31 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.30 | Why? |
| Lymphocyte Subsets | 3 | 2021 | 987 | 0.30 | Why? |
| Infant | 17 | 2021 | 30274 | 0.29 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.29 | Why? |
| Child | 24 | 2021 | 70012 | 0.27 | Why? |
| Acinetobacter baumannii | 2 | 2018 | 378 | 0.27 | Why? |
| Tuberculin Test | 3 | 2019 | 141 | 0.27 | Why? |
| Candida parapsilosis | 2 | 2019 | 34 | 0.25 | Why? |
| Molecular Typing | 2 | 2019 | 280 | 0.21 | Why? |
| Staphylococcus aureus | 2 | 2018 | 844 | 0.21 | Why? |
| Leishmania donovani | 1 | 2020 | 15 | 0.21 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.20 | Why? |
| Candidiasis, Oral | 1 | 2020 | 58 | 0.20 | Why? |
| Coelomomyces | 1 | 2018 | 1 | 0.20 | Why? |
| Antibodies, Protozoan | 1 | 2020 | 121 | 0.19 | Why? |
| Escherichia coli | 2 | 2017 | 1547 | 0.19 | Why? |
| Fluconazole | 2 | 2018 | 145 | 0.19 | Why? |
| Fungal Proteins | 2 | 2018 | 133 | 0.19 | Why? |
| Receptors, Interleukin-12 | 1 | 2018 | 14 | 0.19 | Why? |
| Natamycin | 1 | 2018 | 12 | 0.19 | Why? |
| Drug Resistance, Multiple, Fungal | 1 | 2019 | 45 | 0.19 | Why? |
| Leishmaniasis, Visceral | 1 | 2020 | 85 | 0.19 | Why? |
| Nitroreductases | 1 | 2018 | 2 | 0.19 | Why? |
| Creatine Kinase | 1 | 2021 | 386 | 0.19 | Why? |
| Receptors, Interferon | 1 | 2018 | 64 | 0.19 | Why? |
| Micrococcus | 1 | 2018 | 2 | 0.19 | Why? |
| Brucellosis | 1 | 2019 | 49 | 0.18 | Why? |
| Aspergillus niger | 1 | 2018 | 29 | 0.18 | Why? |
| Meningitis, Bacterial | 1 | 2020 | 111 | 0.18 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2019 | 449 | 0.18 | Why? |
| Magnesium | 1 | 2021 | 290 | 0.18 | Why? |
| Gram-Positive Bacteria | 1 | 2020 | 230 | 0.18 | Why? |
| Mycobacterium Infections | 1 | 2018 | 72 | 0.18 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.18 | Why? |
| Echinococcus granulosus | 1 | 2017 | 18 | 0.18 | Why? |
| RNA, Ribosomal, 23S | 1 | 2017 | 25 | 0.18 | Why? |
| Nalidixic Acid | 1 | 2017 | 6 | 0.18 | Why? |
| Male | 36 | 2021 | 367725 | 0.18 | Why? |
| Enterobacter | 1 | 2017 | 18 | 0.18 | Why? |
| Cefotaxime | 1 | 2017 | 31 | 0.18 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.18 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.17 | Why? |
| Serratia marcescens | 1 | 2017 | 38 | 0.17 | Why? |
| Echinococcosis | 1 | 2017 | 40 | 0.17 | Why? |
| Molecular Epidemiology | 3 | 2019 | 1638 | 0.17 | Why? |
| Enterococcus | 1 | 2018 | 73 | 0.17 | Why? |
| Abdominal Pain | 2 | 2020 | 858 | 0.17 | Why? |
| Dysentery, Bacillary | 1 | 2017 | 38 | 0.17 | Why? |
| Administration, Topical | 1 | 2018 | 272 | 0.17 | Why? |
| Lung Diseases, Fungal | 1 | 2018 | 167 | 0.17 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Amphotericin B | 1 | 2018 | 256 | 0.16 | Why? |
| Bone Marrow | 1 | 2020 | 492 | 0.16 | Why? |
| Female | 33 | 2021 | 380317 | 0.16 | Why? |
| Salmonella Infections | 1 | 2017 | 82 | 0.16 | Why? |
| Aspergillus | 1 | 2019 | 347 | 0.15 | Why? |
| Pathology, Molecular | 1 | 2019 | 343 | 0.15 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Vaccine Potency | 1 | 2017 | 339 | 0.15 | Why? |
| Hospitals | 6 | 2021 | 11793 | 0.15 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2017 | 242 | 0.15 | Why? |
| Candida albicans | 1 | 2017 | 217 | 0.15 | Why? |
| Chemokine CXCL10 | 1 | 2019 | 565 | 0.15 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.14 | Why? |
| Cell Survival | 1 | 2020 | 1581 | 0.14 | Why? |
| Polymerase Chain Reaction | 3 | 2019 | 6740 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2018 | 273 | 0.14 | Why? |
| Invasive Fungal Infections | 1 | 2018 | 274 | 0.14 | Why? |
| Humans | 44 | 2021 | 930598 | 0.14 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2018 | 368 | 0.14 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.14 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.14 | Why? |
| Early Medical Intervention | 1 | 2017 | 487 | 0.13 | Why? |
| Viremia | 1 | 2021 | 1020 | 0.13 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2017 | 801 | 0.13 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.13 | Why? |
| Plasmodium falciparum | 1 | 2017 | 337 | 0.13 | Why? |
| Cross Infection | 4 | 2019 | 8675 | 0.13 | Why? |
| Prevalence | 5 | 2019 | 25773 | 0.13 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.13 | Why? |
| Climate | 1 | 2018 | 557 | 0.12 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.12 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2017 | 782 | 0.12 | Why? |
| Cell Proliferation | 1 | 2020 | 1973 | 0.12 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.12 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.12 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.11 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.11 | Why? |
| Heart Defects, Congenital | 1 | 2021 | 933 | 0.11 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.11 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.11 | Why? |
| Nose | 1 | 2017 | 1093 | 0.10 | Why? |
| Appendicitis | 1 | 2020 | 946 | 0.10 | Why? |
| Genetic Variation | 3 | 2019 | 3919 | 0.10 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.10 | Why? |
| Tachypnea | 2 | 2021 | 197 | 0.10 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.09 | Why? |
| Diarrhea | 2 | 2020 | 2743 | 0.09 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.09 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2019 | 2149 | 0.09 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.09 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.08 | Why? |
| Vomiting | 2 | 2020 | 722 | 0.07 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.07 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Genotyping Techniques | 2 | 2018 | 360 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Retrospective Studies | 7 | 2020 | 105322 | 0.07 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2019 | 5164 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.05 | Why? |
| Amplified Fragment Length Polymorphism Analysis | 1 | 2019 | 11 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Mycological Typing Techniques | 1 | 2019 | 38 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| Clotrimazole | 1 | 2018 | 5 | 0.05 | Why? |
| Random Amplified Polymorphic DNA Technique | 1 | 2018 | 8 | 0.05 | Why? |
| Fever | 3 | 2021 | 7795 | 0.05 | Why? |
| Nystatin | 1 | 2018 | 19 | 0.05 | Why? |
| Erythromycin | 1 | 2018 | 17 | 0.05 | Why? |
| DNA, Helminth | 1 | 2017 | 15 | 0.05 | Why? |
| Tubulin | 1 | 2018 | 67 | 0.05 | Why? |
| Metronidazole | 1 | 2018 | 59 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Methicillin | 1 | 2018 | 73 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Buffaloes | 1 | 2017 | 56 | 0.04 | Why? |
| Paraffin Embedding | 1 | 2018 | 105 | 0.04 | Why? |
| Interleukin-12 | 1 | 2018 | 156 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.04 | Why? |
| Formaldehyde | 1 | 2018 | 135 | 0.04 | Why? |
| RNA, Ribosomal, 18S | 1 | 2017 | 68 | 0.04 | Why? |
| Goats | 1 | 2017 | 217 | 0.04 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.04 | Why? |
| Stomach | 1 | 2018 | 141 | 0.04 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.04 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.04 | Why? |
| ATP-Binding Cassette Transporters | 1 | 2017 | 48 | 0.04 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Linezolid | 1 | 2018 | 160 | 0.04 | Why? |
| Cough | 2 | 2021 | 4891 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Sheep | 1 | 2017 | 420 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Urinalysis | 1 | 2018 | 218 | 0.04 | Why? |
| Drug Resistance, Multiple | 1 | 2017 | 156 | 0.04 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2020 | 323 | 0.04 | Why? |
| Biodiversity | 1 | 2019 | 546 | 0.04 | Why? |
| Phylogeny | 3 | 2019 | 13341 | 0.04 | Why? |
| Drug Resistance, Fungal | 1 | 2017 | 191 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.03 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2020 | 398 | 0.03 | Why? |
| Aspergillosis | 1 | 2018 | 264 | 0.03 | Why? |
| Administration, Intranasal | 1 | 2018 | 1132 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Spleen | 1 | 2017 | 877 | 0.03 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Aged | 8 | 2021 | 215776 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Host Specificity | 1 | 2017 | 926 | 0.03 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Flow Cytometry | 1 | 2021 | 2393 | 0.03 | Why? |
| Bronchi | 1 | 2018 | 1048 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 1439 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.02 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Immunization | 1 | 2018 | 2019 | 0.02 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Thorax | 1 | 2018 | 1873 | 0.02 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Young Adult | 4 | 2019 | 93724 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Parents | 1 | 2017 | 2758 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Lung | 2 | 2020 | 31049 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |